台灣臨床試驗主持人資料庫|TPIDB

2016-12-01 - 2018-06-30

Phase III

An Open-label, Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression

Condition/Disease

Treatment-resistant Depression
Test Drug

ESKETAMINE

Participate Sites
8Sites

Terminated8Sites

李信謙

Taipei Medical University-Shuang Ho Hospital,Ministry of Health and Welfare

Division of Psychiatry

劉嘉逸

Linkou Chang Gung Medical Foundation

Division of Psychiatry

2015-07-01 - 2020-12-31

Phase III

Condition/Disease
Test Drug

Participate Sites
7Sites

Terminated7Sites

李岡遠

Taipei Medical University-Shuang Ho Hospital,Ministry of Health and Welfare

Division of Thoracic Medicine

楊政達

Linkou Chang Gung Medical Foundation

Division of Thoracic Medicine

2017-01-01 - 2020-06-30

Phase III

Study to Evaluate the Effect of Dapagliflozin on the Incidence of Worsening Heart Failure or Cardiovascular Death in Patients with Chronic Heart Failure with Reduced Ejection Fraction

Condition/Disease

Chronic Heart Failure
Test Drug

Forxiga

Participate Sites
15Sites

Terminated13Sites

江晨恩

Taipei Veterans General Hospital

Division of Cardiovascular Diseases

謝宜璋

Linkou Chang Gung Medical Foundation

Division of Cardiovascular Diseases

2018-12-01 - 2024-06-21

Phase I

A Phase IB, Open-Label, Multi-Center Study to Determine the Efficacy and Safety of Durvalumab in Combination With Novel Oncology Therapies, With or Without Chemotherapy, for First-Line Stage IV Non Small Cell Lung Cancer (NSCLC) (MAGELLAN)

Condition/Disease

NSCLC
Test Drug

Durvalumab

Participate Sites
9Sites

Recruiting8Sites

李岡遠

Taipei Medical University-Shuang Ho Hospital,Ministry of Health and Welfare

Division of Thoracic Medicine

楊政達

Linkou Chang Gung Medical Foundation

Division of Hematology & Oncology

2016-11-01 - 2022-10-28

Phase III

A Randomized, Double-blind, Placebo Controlled Phase III Study of Darolutamide (ODM-201) Versus Placebo in Addition to Standard Androgen Deprivation Therapy and Docetaxel in Patients With Metastatic Hormone Sensitive Prostate Cancer

Condition/Disease

metastatic hormone-sensitive prostate cancer
Test Drug

BAY 1841788/ODM-201(Darlutamide)

Participate Sites
8Sites

Recruiting6Sites

黃逸修

Taipei Veterans General Hospital

馮思中

Linkou Chang Gung Medical Foundation

2017-02-01 - 2019-05-09

Phase III

Evaluation of the safety and efficacy of an edoxaban-based compared to a vitamin K antagonist-based antithrombotic regimen following successful percutaneous coronary intervention (PCI) with stent placement. (EdoxabaN Treatment versus VKA in patients with AF undergoing PCI ( ENTRUST-AF PCI)

Condition/Disease

Atrial Fibrillation Following Successful Percutaneous Coronary Intervention (PCI) With Stent Placement
Test Drug

Edoxaban (DU-176b)

Participate Sites
13Sites

Terminated11Sites

江晨恩

Taipei Veterans General Hospital

Division of Cardiovascular Diseases

2017-01-05 - 2019-12-31

Others

An Open-Label, Multicenter Phase Ib Study of The Safety and Efficacy of Atezolizumab (Anti-PD-L1 Antibody) Administered in Combination With Bevacizumab and/or Other Treatments in Patients With Solid Tumors

Condition/Disease

Solid Tumors
Test Drug

TECENTRIQ

Participate Sites
6Sites

Recruiting4Sites

Terminated1Sites

趙毅

Taipei Veterans General Hospital

陳仁熙

Linkou Chang Gung Medical Foundation

2017-11-15 - 2022-12-31

Phase III

A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Demonstrate the Effects of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes, Cardiovascular Risk Factors and Moderately Impaired Renal Function

Condition/Disease

Type 2 Diabetes, Cardiovascular Risk Factors and Moderately Impaired Renal Function
Test Drug

Sotagliflozin

Participate Sites
10Sites

Not yet recruiting1Sites

Terminated7Sites

江晨恩

Taipei Veterans General Hospital

Division of Cardiovascular Diseases

謝宜璋

Linkou Chang Gung Medical Foundation

Division of Cardiovascular Diseases

2018-01-01 - 2022-12-31

Phase III

A Multinational, Multicenter, Randomized, Phase 3 Study of Tesetaxel Plus a Reduced Dose of Capecitabine Versus Capecitabine Alone in Patients With HER2 Negative, HR Positive, Locally Advanced or Metastatic Breast Cancer Previously Treated With a Taxane

Condition/Disease

HER2 Negative, HR Positive, Locally Advanced or Metastatic Breast Cancer Previously Treated With a Taxane
Test Drug

Tesetaxel

Participate Sites
7Sites

Terminated7Sites

趙大中

Taipei Veterans General Hospital

陳訓徹

Linkou Chang Gung Medical Foundation

Division of General Surgery

2017-01-06 - 2022-01-05

Phase III

ONO-4538 Phase III Study A multicenter, double-blind, randomized study in patients with gastric cancer undergoing postoperative adjuvant chemotherapy

Condition/Disease

Gastric Cancer
Test Drug

Nivolumab

Participate Sites
10Sites

Terminated8Sites

白禮源

China Medical University Hospital-Taipei

未分科

陳仁熙

Linkou Chang Gung Medical Foundation

Division of Hematology & Oncology

Search Result

List